Author:
Wen Zhuoyu,Wang Shidan,Yang Donghan M.,Xie Yang,Chen Mingyi,Bishop Justin,Xiao Guanghua
Funder
National Institute of Dental and Craniofacial Research
Cancer Prevention and Research Institute of Texas
National Institutes of Health
National Cancer Institute
National Institute of General Medical Sciences
Subject
Pathology and Forensic Medicine
Reference143 articles.
1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022
2. Cancer treatment and survivorship statistics, 2022;Miller;CA Cancer J Clin,2022
3. Bell, D. New FDA-approved oncology drugs (2021–2022). 2022; Available from: https://ascopost.com/issues/june-3-2022-narratives-special-issue/new-fda-approved-oncology-drugs-2021-2022/.
4. Cancer evolution and heterogeneity;Mimori;Ann Gastroenterol Surg,2018
5. Clinicopathologic factors associated with response to neoadjuvant anti-HER2-directed chemotherapy in HER2-positive breast cancer;Meisel;Clin Breast Cancer,2020
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献